Since receiving the investment in August 2024, the company’s growth has continued to go from strength-to-strength, achieving record turnover in the last financial year.
During the last 12 months the company has also expanded its team members, particularly to continue providing outstanding customer care while the business grows rapidly and to introduce new products into hospital theatres sector, and grown its team to more than 40 employees across the UK and Ireland.
These investments are being recognised: just this month, DP has been shortlisted for in the ‘Best Customer Service’ category at the UK Customer Experience Awards 2025.
Rob Atkinson, chief executive of DP Medical Systems, said: “DP Medical continues to enjoy significant growth, accelerated by the support and investment from Foresight in 2024, which signalled a new era for our business.
“Since then, we’ve been able to grow our team further and focus on the strategic development of our theatre division, headed up by our Theatre & Imaging Manager, Ryan Owens.
“Alongside this, we’ve forged new partnerships with suppliers including one of the world’s leading ENT device manufacturers, SPIGGLE & THEIS, who appointed DP Medical as its exclusive UK distributor in February this year, and we’ve continued to grow our Irish division, too.
“Our partnership with XION Medical has also been a key driver of growth over the last year, with more and more customers across the UK and Ireland recognising the company’s user-friendly, cutting-edge endoscopy systems and instruments.”
As the company’s recent award shortlisting has highlighted, excellence in customer service has also stayed at the forefront of DP Medical’s work, too.
Throughout the last year, the company has maintained its average customer satisfaction rate of nine out of ten, with customer survey respondents also rating the support provided by their direct sales manager or service engineer 9.3 out of 10.
However, the sector continues to face challenges, as Rob explains:
“The headwinds remain, particularly around supply chain issues and the import of medical devices, as well as the changing NHS and continued funding challenges.
“We’re very proud to be helping our customers continue to navigate these hurdles, using our experience and expertise to streamline regulatory requirements for suppliers looking to import into the UK and Irish markets and help connect healthcare practitioners with the latest innovations from around the globe.”
Looking ahead to the next 12 months, DP Medical’s focus remains on continual growth, expanding the team further and building its new theatre and imaging team.
Rob added: “We have a really well-established reputation and customer base in the ENT, gynaecology and dentistry sectors, and we want to replicate that within the theatre environment.
“The next 12 months will see us work to introduce the many groundbreaking products that we already have on offer into that space to help boost patient results and efficiencies for theatre professionals.”
Environmental, social and governance (ESG) policy and carbon reduction also remains a key priority for DP Medical in the coming months and years.
“We’re working hard to reduce DP Medical’s carbon footprint through a number of initiatives,” explained Rob, “from waste management to reviewing our fleet vehicles. We want to reduce our environmental footprint as much as we possibly can, ensuring our customers know DP Medical represents a truly sustainable choice when it comes to picking their supplier, now and in the years to come.”
Matthew Stork, chair of the board of directors at DP Medical and co-investor in the company alongside the Foresight Group, said: "The business has made excellent progress over the year commercially, operationally and on governance and sustainability, while continuing to deliver outstanding service as we have seen in the customer service reports each month. It's been a great start to the working relationship with the new investors and board."
For further information about DP Medical, visit www.dpmedicalsys.com